Next Article in Journal
Introduction to “Immunotherapies for Multiple Myeloma”
Previous Article in Journal
Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Solubility, Solution Thermodynamics, and Preferential Solvation of Amygdalin in Ethanol + Water Solvent Mixtures

1
LETIAM, Lip (Sys)2, IUT d’Orsay, Université Paris-Sud, Plateau de Moulon, 91400 Orsay, France
2
Laboratory of Materials Molecules and Applications, Preparatory Institute for Scientific and Technical Studies, University of Carthage, Tunis 1082, Tunisia
3
Laboratory of Materials, Treatment and Analysis (LMTA), National Institute of Research and Physicochemical Analysis (INRAP), BiotechPole Sidi-Thabet, Ariana 2020, Tunisia
4
Faculté des Sciences de Tunis, Université Tunis El Manar, Campus Universitaire El Manar, Tunis 2092, Tunisia
5
Department of Industrial Engineering and Systems, College of Engineering, Princess Nourah bint Abdulrahman University, Riyadh 84428, Saudi Arabia
6
Department of Chemical and Materials Engineering, Faculty of Engineering, Northern Border University, Arar P.O. Box 1321, Saudi Arabia
7
GRIAUCC Research Group, Department of Engineering, Industrial Engineering Program, Universidad Cooperativa de Colombia, Calle 11 No. 1-51, Neiva 410001, Huila, Colombia
8
Department of Pharmaceutical and Chemical Engineering, Faculty of Applied Medical Sciences, German Jordanian University, Amman 11180, Jordan
9
Department of Mechanical Engineering, College of Engineering, Ha’il University, Ha’il City 81481, Saudi Arabia
10
Laboratory of Metrology and Energy Systems, National Engineering School of Monastir, University of Monastir, Monastir 5000, Tunisia
*
Author to whom correspondence should be addressed.
Pharmaceuticals 2020, 13(11), 395; https://doi.org/10.3390/ph13110395
Submission received: 14 October 2020 / Revised: 10 November 2020 / Accepted: 12 November 2020 / Published: 16 November 2020
(This article belongs to the Section Pharmaceutical Technology)

Abstract

:
The equilibrium solubility of amygdalin in [ethanol (1) + water (2)] mixtures at 293.15 K to 328.15 K was reported. The thermodynamic properties (standard enthalpy ΔsolnH°, standard entropy ΔsolnS°, and standard Gibbs energy of solution ΔsolnG°) were computed using the generated solubility data via van’t Hoff and Gibbs equations. The dissolution process of amygdalin is endothermic and the driving mechanism in all mixtures is entropy. Maximal solubility was achieved in 0.4 mole fraction of ethanol at 328.15 K and the minimal one in neat ethanol at 293.15 K. Van’t Hoff, Jouyban–Acree–van’t Hoff, and Buchowski–Ksiazczak models were used to simulate the obtained solubility data. The calculated solubilities deviate reasonably from experimental data. Preferential solvation parameters of amygdalin in mixture solvents were analyzed using the inverse Kirkwood–Buff integrals (IKBI) method. Amygdalin is preferentially solvated by water in ethanol-rich mixtures, whereas in water-rich mixtures, there is no clear evidence that determines which of water or ethanol solvents would be most likely to solvate the molecule.

1. Introduction

Amygdalin (Figure 1) is a naturally occurring cyanogenic diglycoside with a molecular formula of C20H27NO11 and a molecular mass of 457.4 g mol−1. It is a major bioactive component present mostly in kernels and seeds of “Rosaceae” plants such as peaches, apples, cherries, and more [1,2]. The use of amygdalin can lead to the release of toxic hydrogen cyanide (HCN) through the action of emulsin enzyme from the human intestinal microflora [3]. The HCN selectively decomposes cancer cells in the tumor site inside the body [4,5]. Several studies have demonstrated the antitumor activities of amygdalin on prostate cancer, bladder cancer, lung cancer, rectal cancer, and colon cancer [6]. Furthermore, highly purified amygdalin used in therapeutic dosage levels has antioxidant, anti-fibrosis [7], anti-inflammatory, analgesic [8,9], anti-atherosclerosis [10,11,12], anti-cardiac hypertrophy [13], anti-ulcer [14], anti-tussive, and anti-asthmatic effects [15].
Besides the degradation of amygdalin caused by enzymes from the gut microflora, plant enzymes (β-glucosidases and α-hydroxynitrile lyases) can lead to the production of cyanide when plant tissue is damaged or seeds are crushed or macerated. Enzymatic degradation of amygdalin to gentibiose, benzaldehyde, and HCN usually takes place in an alkaline solution [16].
In addition to enzymatic hydrolysis mentioned above, amygdalin degradation can also occur in boiling water through the process of epimerization, particularly under mild basic conditions as well as in a long extraction time [17,18,19]. In Bolarinwa et al.’s research [17], it was demonstrated that at 100 °C of boiling water, an extended extraction period can result in reduced extraction yield due to the conversion of amygdalin into neoamygdalin (amygdalin epimer).
Extracting a high rate of amygdalin from food plants without causing degradation of the molecule is challenging to achieve. Therefore, the selectivity of a solvent for this compound is a crucial parameter, as this will have a paramount influence on the extraction process. Extraction rate and time can be considerably affected by amygdalin solubility in solvents [17]. It is therefore of some interest to know the solubility of amygdalin in different mixtures of solvents. On the other hand, the knowledge of the solubility behavior in different solvent systems is of high importance in the pharmaceutical industry as it influences the drug efficacy and its pharmacokinetics [20]. Solubility data are also useful for drug purification, refining procedures, and method development [21,22,23].
For the above-mentioned reasons, the solubility and solution thermodynamics of amygdalin in pure and solvent mixtures are quite essential and must be determined. The binary water and ethanol mixtures are the most versatile and most used solvent systems for these previous purposes [24,25,26,27].
Thus, the goals of this study were (1) to extend the database on the solubility of amygdalin in several ethanol (1) + water (2) mixtures over a temperature range of 298.105 to 328.15 K, (2) to study the effect of solvent composition on the solubility and solution thermodynamics of amygdalin in aqueous ethanol mixtures, (3) to calculate the apparent thermodynamic functions of solution in the investigated solvents using the van’t Hoff and Gibbs equations, and (4) to estimate the preferential solvation of amygdalin in these solvents through the method of inverse Kirkwood–Buff integrals (IKBI), which describes the local solvent proportions around the dissolved substance concerning to the composition of the cosolvent mixtures [28,29]. Some models were used to predict the solubility of amygdalin in ethanol–water mixtures at different temperatures.

2. Results and Discussion

2.1. Solubility of Amygdalin in [Ethanol (1) + Water (2)] Cosolvent Mixtures

Table 1 shows the experimental solubility of amygdalin (3) in {ethanol (1) + water (2)} cosolvent mixtures including EtOH and water neat solvents at nine temperatures (293.15–328.15 K).
Experimental results demonstrate that the solubility increases with temperature indicating endothermic dissolution (Figure 2A). The maximum solubility of amygdalin was observed in the cosolvent mixture x1 = 0.4 at 328.15 K (Figure 2B). The addition of ethanol (in water-rich mixtures) has a positive cosolvent effect, enhancing amygdalin solubility. Indeed, the presence of the non-polar phenyl group in the amygdalin chemical structure may cause the formation of a structured water layer around it. As the proportion of ethanol in the solvent mixture increases, the solvation water shell will be ruptured [30,31,32], therefore, increasing amygdalin’s solubility in the system.
The solubility profiles of amygdalin in {ethanol (1) + water (2)} binary mixtures at different temperatures were plotted as a function of the Hildebrand solubility parameter δ1 + 2 of the mixtures (Figure 2C).
For binary mixtures, δ1 + 2 is calculated as [33]:
δ 1   +   2 = f 1 δ 1 + ( 1 f 1 ) δ 2
where δ1 and δ2 are the Hildebrand solubility parameters of the pure solvents (δ1 = 26.5 MPa1/2 for ethanol (1) [34] and δ2 = 47.8 MPa1/2 for water (2) [34]; f is the solute-free volume fraction which is calculated assuming additive volumes as:
f = V1/(V1 + V2)
where V1 and V2 are the volumes of cosolvent and water, respectively.
Considering the entire polarity region, the solubility increases from pure water (δ = 47.8 MPa1/2) up to the mixture with x1 = 0.40 (δmix = 33.2 MPa1/2), where the curve shows a maximum solubility peak; from this mixture up to pure ethanol, the solubility decreases in all cases (Figure 2C).
This behavior is commonly observed in compounds whose polarity coincides with the polarity of a mixture of solvents (δ1 > δ3 > δ2 or δ2 > δ3 > δ1) [35,36].
According to the literature, solutes reach their maximum solubility in solvents with the same solubility parameter [36] and thus, the δ3 value of amygdalin (3) would be 33.2 MPa1/2. However, the solubility parameter of amygdalin (3), estimated in accordance with the group contribution methods proposed by Fedors and van Krevelen, is δ3 = 29.9 MPa1/2 (Table 2), which is lower than the experimental value obtained in this work at the solubility maximum (δ3 = 33.2 MPa1/2).
It is important to note that the group contribution methods only provide a rough estimation of δ3; however, this calculation is relevant to identify the most suitable solvent or solvent mixture to dissolve the drug, which is useful information in experimental and industrial designs.

2.2. Computational Validation

The use of calculation models to predict the solubility of chemicals in mixed solvents is one of the lines of research that have evolved the most in recent years. Some of the most widely implemented models are those of, van’t Hoff, Jouyban–Acree–van’t Hoff and Buchowski–Ksiazczak λh.
Thus, the van’t Hoff equation (Equation (3)) presents a relationship between solubility (expressed in mole fraction) and temperature.
x 3 = e ( A   +   B T )
A and B are parameters, which can be related to thermodynamic parameters such as dissolution enthalpy and dissolution entropy [37].
Jouyban and Acree developed a specific model for the prediction of the solubility of drugs in {ethanol (1) + water (2)} cosolvent mixtures at a specific temperature (Equation (4)) [38,39,40]:
ln x 3 , 1 + 2 = x 1 ln x 3 , 1   +   x 2 ln x 3 , 2 +   x 1 x 2 [ 724.21 T 1   +   485.17 ( x 1 x 2 ) T 1   +   194 . 41 ( x 1 x 2 ) 2 T 1 ]
Introducing the van’t Hoff model, the Jouyban–Acree would be left, with the advantage of being able to calculate solubility at various temperatures [41].
ln x 3 , 1 + 2 = x 1 ( A 1 + B 1 T 1 ) + x 2 ( A 2 + B 2 T 1 ) + x 1 x 2 [ 724.21 T 1   +   485.17 ( x 1 x 2 ) T 1   +   194.41 ( x 1 x 2 ) 2 T 1 ]
For this investigation, when calculating A and B coefficients by linear regression, the following equation is obtained:
ln x 3 , 1 + 2 = x 1 ( 0.69 ± 0.22 2048 T 1 ) + x 2 ( 8.06 ± 0.28 4101 ± 87 T 1 ) + x 1 x 2 [ 724.21 T 1 + 485.17 ( x 1 x 2 ) T 1 + 194.41 ( x 1 x 2 ) 2 T 1 ]
The Buchowski–Ksiazczak λh equation, (Equation (8)), is another way to describe the solubility behavior:
x 3 = λ e λ h T f 1 λ e λ h T f 1 e λ h T f 1 + e λ h T 1
where λ and h are the two parameters of the Buchowski–Ksiazczak model, and Tf represents the melting point of drug [42,43,44].
The mean percentage deviation (MPD) was calculated from Equation (8) [45,46]:
MPD = 100 N | x 3 , 1 + 2 cal x 3 , 1 + 2 Exp | x 3 , 1 + 2 Exp
where N is the number of experimental data points, and   x 3 , 1 + 2 cal and x 3 , 1 + 2 Exp are the calculated and experimental solubility values.
Thus, amygdalin solubility was estimated employing Equations (3), (6), and (7) and then, the MPD values were calculated using Equation (8).
The MDP values show that the model that best predicts the experimental data is the van’t Hoff model (3.3%), followed by the Buchowski–Ksiazczak model (4.3%), and finally, the Jouyban–Acree–van’t Hoff mode presents a MDP of 22.8%.
Figure 3 shows the calculated solubility versus observed solubility data of amygdalin in {ethanol (1) + water (2)} cosolvent mixtures, using the van’t Hoff, Jouyban–Acree–van’t Hoff and Buchowski–Ksiazczak models. A relatively low determination coefficient was observed (R2 = 0.76) indicating a poor prediction accuracy for the Jouyban–Acree–van’t Hoff model; however, the van’t Hoff and Buchowski–Ksiazczak models present correlation coefficients close to one, indicating a good correlation of the data calculated with these models and the experimental data.
Therefore, in general terms, the Jouyban–Acree–van’t Hoff model does not predict the solubility of amygdalin in {ethanol (1) + water (2)} cosolvent mixtures adequately; however, the van’t Hoff and Buchowski–Ksiazczak models show very good precision, as demonstrated with the MDP values.

2.3. Thermodynamic Functions of Dissolution

From the experimental solubility data (Table 1), the thermodynamic functions of dissolution (Table 3) were calculated using the van’t Hoff and Gibbs equations, under Krug modifications [47,48]:
soln H o = R ( ln x 3 / ( T 1 T hm 1 ) )
soln G o = R × T hm × intercept
soln S o = ( soln H o soln G o ) T hm 1
where soln H o represents the solution standard enthalpy, soln S o represents the solution standard entropy, soln G o represents the solution standard Gibbs energy, R represents the constant of gases, and Thm represents the mean harmonic temperature defined as: Thm = n/Σ(1/T), where n is the number of studied temperatures (the harmonic mean temperature for this investigation is 310.22 K).
Upon graphing ln x3 vs. (T−1Thm−1), the slope (∂ln x3/∂ (T−1Thm−1)) and intercept used in Equations (10) and (11) are obtained.
Table 3 shows the data for the apparent thermodynamic functions of solution for amygdalin, ΔsolnHo, ΔsolnGo,and ΔsolnSo. The values of the slope and intercept with their respective standard deviations were calculated using the TableCurve 2D program. The resulting graphs are linear for each of the EtOH + W cosolvent mixtures, obtaining correlation coefficients very close to 1 for first order linear regressions (y = a + bx) (Figure 4).
The standard Gibbs energy ΔsolnG° (Table 3) is positive over the whole composition range and decreases from neat water to the cosolvent mixture x1 = 0.4. From this solvent composition to pure EtOH, ΔsolnG° increases. The ΔsolnH° is positive in every case indicating that the process of dissolution of amygdalin powder in solvents is endothermic [49,50]. The enthalpic values increase nonlinearly from neat water up to 40% in volume of EtOH, presumably because, by increasing ethanol content, the interaction of this solvent with the solute promotes the breaking of the structured water molecules (hydrogen bonds) around the non-polar group of amygdalin [33,51]. As for the standard entropy of solution (ΔsolnS°), it is negative for pure ethanol, while it is positive for water-rich mixtures, suggesting an overall entropy-driven process for the latter mixtures. The relative contributions by enthalpy (ζH) and by entropy (ζTS) toward standard Gibbs free energy of solution are given by Equations (12) and (13), respectively:
ζ H = | Δ soln H o | ( | Δ soln H o | + | T hm Δ soln S o | ) 1
ζ T S = | T hm Δ soln S o | ( | Δ soln H o | + | T hm Δ soln S o | ) 1
It may be seen from Table 4 that, in all cases, the main contributor to the (positive) standard Gibbs energy of dissolution is the (positive) enthalpy term (ζH > 0.59).

2.4. Enthalpy–Entropy Compensation

The study of enthalpy–entropy compensation effects for solute dissolution has been used to identify the main mechanism involved in the cosolvent behavior on dissolution processes [52,53]. Plots of ∆solnHo as a function of ∆solnGo or T∆solnSo at the harmonic temperature are employed for this purpose.
Thus, when plotting ∆solnHo vs. ∆solnGo, a positive slope will indicate an enthalpy-driven dissolution process, while a negative one will indicate an entropy-driven dissolution process [39].
Similarly, when plotting ∆solnHo vs. T∆solnSo, a slope greater than one will indicate an enthalpy-driven dissolution processes while a slope of less than one indicates entropy-driven dissolution processes [7,52,53,54,55,56].
Figure 5 shows that amygdalin in {ethanol (1) + water (2)} mixture solvents exhibits two trends, both with a negative slope, suggesting that the whole dissolution process is driven by entropy.
When plotting ∆solnHo vs. TsolnSo (Figure 6), a linear trend is observed, described by the following equation: ∆SolnHo = 0.758 ± 0.014TSolnSo + 18.15 ± 0.25. The slope is inferior to 1, which corroborates the previous results.

2.5. Preferential Solvation

The preferential solvation model suggested by Ben Naim, called the inverse Kirkwood–Buff Integral (IKBI), allows determining, at the molecular level, the arrangement of the solvent molecules that make up the cosolvent mixture around a dissolved solute molecule [57,58,59].
This model allows to obtain the preferential solvation parameter of amygdalin (3) by ethanol molecules ( δ x 1 , 3 ) according to [60,61,62]:
δ x 1 , 3 = [ x 1 ( 1 x 1 ) ( G 1 , 3 G 2 , 3 ) ] [ x 1 G 1 , 3 + ( 1 x 1 ) G 2 , 3 + V c o r ] 1
where x1 is the molar fraction of ethanol-free amygdalin, G1,3 and G2,3 are the Kirkwood–Buff integrals (cm3 mol−1), and Vcor is the correlation volume (cm3 mol−1).
Thus, G 1 , 3 and G 2 , 3 are calculated as [63,64]:
G 1 , 3 = R T κ T V 3 + ( 1 x 1 ) V 2 D Q 1
G 2 , 3 = R T κ T V 3 + x 1 V 1 D Q 1
where κT is the isothermal compressibility of ethanol + water mixtures (GPa−1), V1 and V2 are the molar volumes of ethanol and water, respectively, in the mixtures (cm3 mol−1), and V3 is the molar volume of amygdalin in the mixed solvent (cm3 mol−1)
Vcor is defined as [65,66]:
V c o r = 2522.5 [ r 3 + 0.1363 x 1 , 3 L V 1 + x 2 , 3 L V 2 3 0.085 ] 3
where x1,3L is the local molar fraction of ethanol (1) in the surrounding area of amygdalin (3) and r3 is the amygdalin molecular radius (nm).
Vcor is calculated by iteration using Equations (15) and (18) [67]:
                δ x 1 , 3 = x 1 , 3 L x 1
The functions D and Q (kJ mol−1) are calculated using the following equations:
Q = R T + x 1 x 2 ( 2 G 1 , 2 E x 2 2 ) T , P
D = ( t r G 3 , 2 1 + 2 o / x 1 ) T , P
trGo3,2→1 + 2 is the standard molar Gibbs energy of transfer of the solute from pure water to each {ethanol (1) + water (2)} mixture and GE1,2 is the excess molar Gibbs energy of mixing of the two solvents free of amygdalin.
Figure 7 shows the behavior of the Gibbs energy of transfer of amygdalin (3) from pure water (2) to {ethanol (1) + water (2)} mixtures at several temperatures. The numerical values were computed from the experimental solubility data (Table 1), by using the following equation:
t r G 3 , 2 1 + 2 o = R T ln ( x 3 , 2 x 3 , 1 + 2 1 )
t r G 3 , 2 1 + 2 o = a + b x 1 + c x 1 2 + d x 1 3 + e x 1 4
Table 4 records the numerical values of the coefficients of Equation (22) at 293.15, 298.15, 303.15, 308.15, and 313.15 K.
On the other hand, Q is calculated according to Equation (19), where G1.2E is calculated as [64]:
G 1 , 2 E = x 1 x 2 [ 2907 777 ( 1 2 x 1 ) + 494 ( 1 2 x 2 ) 2 ]
Once D and Q are calculated together with the isothermal compressibility (κT) for water (0.457 GPa−1) [68] and ethanol (1.248 GPa−1), in addition to the molar volumes of amygdalin and the solvents in the binary mixture reported by Jiménez et al. [69], the Kirkwood–Buff integrals are calculated, and from these, the preferential solvation parameters δx1,3 of amygdalin in the binary solvent mixtures at the studied temperatures are calculated [70].
According to the literature, positive values of δx1,3 indicate preferential solvation of amygdalin by ethanol. Conversely, negative values of δx1,3 indicate preferential solvation of amygdalin by water.
The values of δx1,3 are presented in Table 5 and the behavior of δx1,3 is illustrated in Figure 8. Thus, from neat water to x1 = 0.45, the absolute value of δx1,3 is inferior to 0.01, indicating insignificant preferential solvation, probably because the values are within the error of the measurement [60]. From this composition to pure ethanol, the values of δx1,3 are negative and greater than 0.01. The maximum negative δx1,3 value is reached in the mixture x1 = 0.75 (Figure 8). These results indicate the preferential solvation of amygdalin by water. Because of the availability of two sugar moieties in the molecular structure of amygdalin, this molecule can form hydrogen bonds with proton-acceptor solvents. At the same time, amygdalin can act as a proton-acceptor (base group) molecule due to the free electron pair of the oxygen atom in the OH group or nitrogen atom of the C≡N group. Thus, the tendency of amygdalin for water in ethanol-rich mixtures could be explained in the matter of the greater acidic character of water (1.17 for water and 0.86 for ethanol, as stated in the acid scale of Taft and Kamlet [71]) interacting with proton-acceptor groups of amygdalin.

3. Experimental procedures

3.1. Reagents

Amygdalin (purity 98%) and HPLC-grade ethanol (purity 99.9%) were acquired from Sigma-Aldrich (San Luis, WA, USA).
Doubly distilled and deionized water were used in all experiments. All chemicals were used without further purification.

3.2. Solubility Determination

The employed techniques to prepare ethanol–water binary solvent mixtures and to measure the solubility of amygdalin in these solvents were used as reported in different studies [72,73,74]. The solubility of amygdalin in pure and mixed solvents was investigated at different temperatures in the range of 298.15–328.15 K. The gravimetric method was used to measure the composition of the saturated solutions.
The solvent mixtures were prepared by mass using a Sartorius balance (CP225D) with an accuracy of ±0.01 mg. An excess of amygdalin powder was added to the liquid phase, and the saturated solutions were brought into a twofold jacketed reactor (Polystat Huber CC2) at T ± 0.1 K. The solutions are magnetically stirred at the desired temperature for at least 72 h to ensure the saturation equilibrium. Thereafter, they were allowed to settle for 2 h before sampling.
The supernatant solutions were withdrawn, filtered through a 0.45-µm syringe filter, and then dried in a vacuum oven at 328.15 K. The mass of the dried samples was periodically measured using an analytical balance until stability. All determinations were performed three times to check reproducibility, and then an average value was taken to determine the amygdalin solubility in all systems at each condition. The solubility of amygdalin was calculated by molar fraction ( x A ) in pure and different binary ethanol–water mixtures using the Equations (1) and (2), respectively.

4. Conclusions

The solubilities of amygdalin in {ethanol (1) + water (2)} mixtures were determined at different temperatures. The maximum solubility was obtained in 0.4-mole fraction of ethanol at 328.15 K and the lowest one in pure ethanol at 293.15 K. The amygdalin solubility was calculated using the van’t Hoff, Jouyban–Acree-van’t Hoff, and Buchowski-–Ksiazczak models, the data obtained using the Jouyban–Acree–van’t Hoff model showing important deviations with respect to experimental solubility; however, the van’t Hoff and Buchowski–Ksiazczak models showed a good correlation with the experimental data. As for solution thermodynamics, an endothermic process was observed, with a pronounced enthalpic contribution, but with entropic conduction.
The IKBI approach demonstrated that amygdalin is preferentially solvated by water in ethanol-rich mixtures, which is consistent with the decrease in amygdalin solubility by the addition of ethanol. Whereas, in water-rich mixtures (0 < x1 < 0.45), the solvent that will solvate the amygdalin molecule was not well defined.
In general terms, the data presented in this research expand the physicochemical information of amygdalin in binary aqueous-cosolvent mixtures, which are very useful, both for the pharmaceutical industry and for research processes related to this drug.

Author Contributions

Formal analysis, M.A.; Funding acquisition, K.G.; Methodology, C.A., K.G. and L.K.; Supervision, D.R.D.; Validation, A.Z.A.-K.; Writing—review & editing, A.A. and K.G. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Deanship of Scientific Research at Princess Nourah bint Abdulrahman University through the Fast-track Research Funding Program.

Conflicts of Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

References

  1. Jaswal, V.; Palanivelu, J.; Ramalingam, C. Effects of the Gut microbiota on Amygdalin and its use as an anti-cancer therapy: Substantial review on the key components involved in altering dose efficacy and toxicity. Biochem. Biophys. Rep. 2018, 14, 125–132. [Google Scholar] [CrossRef]
  2. Guo, J.; Wu, W.; Sheng, M.; Yang, S.; Tan, J. Amygdalin inhibits renal fibrosis in chronic kidney disease. Mol. Med. Rep. 2013, 7, 1453–1457. [Google Scholar] [CrossRef] [Green Version]
  3. Carter, J.H.; McLafferty, M.A.; Goldman, P. Role of the gastrointestinal microflora in Amygdalin (laetrile)-induced cyanide toxicity. Biochem. Pharmacol. 1980, 29, 301–304. [Google Scholar] [CrossRef]
  4. Li, Y.; Li, Q.; Liu, R.; Shen, X. Chinese Medicine Amygdalin and β-Glucosidase Combined with Antibody Enzymatic Prodrug System as A Feasible Antitumor Therapy. Chin. J. Integr. Med. 2015, 24, 237–240. [Google Scholar] [CrossRef]
  5. Moon, J.Y.; Kim, S.W.; Yun, G.M.; Lee, H.S.; Kim, Y.D.; Jeong, G.J.; Ullah, I.; Rho, G.J.; Jeon, B.G. Inhibition of cell growth and down-regulation of telomerase activity by Amygdalin in human cancer cell lines. Anim. Cells Syst. 2015, 19, 295–304. [Google Scholar] [CrossRef] [Green Version]
  6. Song, Z.; Xu, X. Advanced research on anti-tumor effects of Amygdalin. J. Cancer Res. Ther. 2014, 10, 3. [Google Scholar]
  7. Zhang, X.; Hu, J.; Zhuo, Y.; Cui, L.; Li, C.; Cui, N.; Zhang, S. Amygdalin improves microcirculatory disturbance and attenuates pancreatic fibrosis by regulating the expression of endothelin-1 and calcitonin gene-related peptide in rats. J. Chin. Med. Assoc. 2018, 81, 437–443. [Google Scholar] [CrossRef]
  8. Hwang, H.J.; Lee, H.J.; Kim, C.J.; Shim, I.; Hahm, D.H. Inhibitory effect of Amygdalin on lipopolysaccharide-inducible TNF-alpha and IL-1beta mRNA expression and carrageenan-induced rat arthritis. J. Microbiol. Biotechnol. 2008, 18, 1641–1647. [Google Scholar]
  9. Zhu, Y.P.; Su, Z.W.; Li, C.H. Analgesic effect and no physical dependence of Amygdalin. China J. Chin. Mater. Med. 1994, 19, 105–107. [Google Scholar]
  10. Jiagang, D.; Li, C.; Wang, H.; Hao, E.; Du, Z.; Bao, C.; Lv, J.; Wang, Y. Amygdalin mediates relieved atherosclerosis in apolipoprotein E deficient mice through the induction of regulatory T cells. Biochem. Biophys. Res. Commun. 2011, 411, 523–529. [Google Scholar] [CrossRef] [PubMed]
  11. Zhao, F.; Yang, Z. Amygdalin attenuates atherosclerosis progress through inhibiting of toll-like receptors expression and activity. J. Anim. Vet. Adv. 2012, 11, 1613–1621. [Google Scholar] [CrossRef] [Green Version]
  12. Wang, Z.; Fang, K.; Wang, G.; Guan, X.; Pang, Z.; Guo, Y.; Yuan, Y.; Ran, N.; Liu, Y.; Wang, F. Protective effect of Amygdalin on epithelial—mesenchymal transformation in experimental chronic obstructive pulmonary disease mice. Phytother. Res. 2019, 33, 808–817. [Google Scholar] [CrossRef] [PubMed]
  13. He, X.Y.; Wu, L.J.; Wang, W.X.; Xie, P.J.; Chen, Y.H.; Wang, F. Amygdalin-A pharmacological and toxicological review. J. Ethnopharmacol. 2020, 112717. [Google Scholar] [CrossRef]
  14. Nabavizadeh, F.; Alizadeh, A.M.; Sadroleslami, Z.; Adeli, S. Gastroprotective effects of Amygdalin on experimental gastric ulcer: Role of NO and TNF-α. J. Med. Plant Res. 2011, 5, 3122–3127. [Google Scholar]
  15. Lee, H.M.; Moon, A. Amygdalin regulates apoptosis and adhesion in Hs578T triple-negative breast cancer cells. Biomol. Ther. 2016, 24, 62. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Haisman, D.R.; Knight, D.J. The enzymic hydrolysis of Amygdalin. Biochem. J. 1967, 103, 528–534. [Google Scholar] [CrossRef] [Green Version]
  17. Bolarinwa, I.F.; Orfila, C.; Morgan, M.R. Amygdalin content of seeds, kernels and food products commercially-available in the UK. Food Chem. 2014, 52, 133–139. [Google Scholar] [CrossRef] [Green Version]
  18. Krieble, V.K. The amygdalins and their inter-reactions with emulsin. J. Am. Chem. Soc. 1912, 34, 716–735. [Google Scholar] [CrossRef] [Green Version]
  19. Boháčová, I.; Procházková, S.; Halko, R. Separation and determination of Amygdalin and unnatural neoAmygdalin in natural food supplements by HPLC-DAD. Food Addit. Contam. Part A 2019, 36, 1445–1452. [Google Scholar] [CrossRef]
  20. Thapa, R.K.; Choi, H.G.; Kim, J.O.; Yong, C.S. Analysis and optimization of drug solubility to improve pharmacokinetics. J. Pharm. Investig. 2017, 47, 95–110. [Google Scholar] [CrossRef]
  21. Pacheco, D.P.; Martínez, F. Thermodynamic analysis of the solubility of naproxen in ethanol + water cosolvent mixtures. Phys. Chem. Liq. 2007, 45, 581–595. [Google Scholar] [CrossRef]
  22. Di, L.; Fish, P.V.; Mano, T. Bridging solubility between drug discovery and development. Drug Discov. Today 2012, 17, 486–495. [Google Scholar] [CrossRef]
  23. Sun, H.; Li, M.; Jia, J.; Tang, F.; Duan, E. Measurement and correlation of the solubility of 2, 6-diaminohexanoic acid hydrochloride in aqueous methanol and aqueous ethanol mixtures. J. Chem. Eng. Data. 2012, 57, 1463–1467. [Google Scholar] [CrossRef]
  24. Delgado, D.R.; Martínez, F. Solubility and solution thermodynamics of sulfamerazine and sulfamethazine in some ethanol+ water mixtures. Fluid Phase Equilibria 2013, 360, 88–96. [Google Scholar] [CrossRef]
  25. Pobudkowska, A.; Domańska, U.; Jurkowska, B.A.; Dymczuk, K. Solubility of pharmaceuticals in water and alcohols. Fluid Phase Equilibria 2015, 392, 56–64. [Google Scholar] [CrossRef]
  26. Allen, L.; Ansel, H.C. Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems; Lippincott Williams & Wilkins: Philadelphia, PA, USA, 2013. [Google Scholar]
  27. Wijesekera, R.O.B. The Medicinal Plant Industry; Routledge: Abingdon-on-Thames, UK, 2017. [Google Scholar]
  28. Marcus, Y. Preferential solvation in mixed solvents. In Fluctuation Theory of Solutions: Applications in Chemistry, Chemical Engineering, and Biophysics; CRC Press: Boca Raton, FL, USA, 2013; pp. 65–92. [Google Scholar]
  29. Marcus, Y. Preferential solvation of drugs in binary solvent mixtures. Pharm. Anal. Acta 2017, 8, 537. [Google Scholar] [CrossRef]
  30. Yalkowsky, S.H. Solubility and Solubilization in Aqueous Media; American Chemical Society: New York, USA, 1999. [Google Scholar]
  31. Williams, R.O., III; Watts, A.B.; Miller, D.A. Formulating Poorly Water Soluble Drugs; American Association of Pharmaceutical Scientists: Austin, TX, USA, 2016. [Google Scholar]
  32. Delgado, D.R.; Rodríguez, G.A.; Martínez, F. Thermodynamic study of the solubility of sulfapyridine in some ethanol + water mixtures. J. Mol. Liq. 2013, 177, 156–161. [Google Scholar] [CrossRef]
  33. Muñoz, M.d.; Delgado, D.R.; Peña, M.Á.; Jouyban, A.; Martínez, F. Solubility and preferential solvation of sulfadiazine, sulfamerazine and sulfamethazine in propylene glycol + water mixtures at 298.15 K. J. Mol. Liq. 2015, 204, 132–136. [Google Scholar] [CrossRef]
  34. Barton, A. CRC Handbook of Solubility Parameters and Other Cohesion Parameters, 2nd ed.; CRC Press: New York, NY, USA, 1991. [Google Scholar]
  35. Delgado, D.R.; Mogollon-Waltero, E.M.; Ortiz, C.P.; Peña, M.; Almanza, O.A.; Martínez, F.; Jouyban, A. Enthalpy-entropy compensation analysis of the triclocarban dissolution process in some {1,4-dioxane (1) + water (2)} mixtures. J. Mol. Liq. 2018, 271, 522–529. [Google Scholar] [CrossRef]
  36. Hildebtand, J.H.; Prausnitz, J.M.; Scott, R.L. Regular and Related Solutions: The Solubility of Gases, Liquids, and Solids; Van Nostrand Reinhold Company: New Tork, NY, USA, 1970. [Google Scholar]
  37. Grant, D.J.W.; Mehdizadeh, M.; Chow, A.H.L.; Fairbrother, J.E. Non-linear van’t Hoff solubility-temperature plots and their pharmaceutical interpretation. Int. J. Pharm. 1984, 18, 25–38. [Google Scholar] [CrossRef]
  38. Jouyban, A.; Acree, W.E. Mathematical derivation of the Jouyban-Acree model to represent solute solubility data in mixed solvents at various temperatures. J. Mol. Liq. 2018, 256, 541–547. [Google Scholar] [CrossRef]
  39. Ruidiaz, M.; Delgado, D.R.; Martínez, F. Correlating the solubility of indomethacin in 1,4-dioxane + water mixtures by means of the Jouyban-Acree model. Rev. Colomb. Cienc. Químico Farm. 2010, 39, 211–226. [Google Scholar]
  40. Acree, W.; Jouyban, A.; Acree, W.E. In silico prediction of drug solubility in water-ethanol mixtures using Jouyban-Acree model. J. Pharm Pharm. Sci. 2006, 9, 262–269. [Google Scholar]
  41. Nieto, A.M.R.; Cerquera, N.E.; Delgado, D.R. Measurement and correlation of solubility of ethylparaben in pure and binary solvents and thermodynamic properties of solution. Rev. Colomb. Cienc. Químico Farm. 2019, 48, 332–347. [Google Scholar] [CrossRef]
  42. Ksia̧ẑczak, A.; Kosinski, J.J. Vapour pressure of binary, three-phase (S-L-V) systems and solubility. Fluid Phase Equilibria 1988, 44, 211–236. [Google Scholar] [CrossRef]
  43. Ksiazczak, A.; Moorthi, K.; Nagata, I. Solid-solid transition and solubility of even n-alkanes. Fluid Phase Equilibria 1994, 95, 15–29. [Google Scholar] [CrossRef]
  44. Krajangsod, S.; Chotikamas, S.; Tawai, A.; Sriariyanun, M. Measurement and thermodynamic modelling of erythritol solubility in aqueous solvents. Orient. J. Chem. 2018, 34, 265–275. [Google Scholar] [CrossRef] [Green Version]
  45. Blanco-Márquez, J.H.; Quigua-Medina, Y.A.; García-Murillo, J.D.; Castro-Camacho, J.K.; Ortiz, C.P.; Cerquera, N.E.; Delgado, D.R. Thermodynamic analysis and applications of the Abraham solvation parameter model in the study of the solubility of some sulfonamides. Rev. Colomb. Cienc. Químico-Farm. 2020, 49, 234–255. [Google Scholar]
  46. Khoubnasabjafari, M.; Delgado, D.R.; Martinez, F.; Jouyban, A.; Acree, W.E. Predicting the solubility, thermodynamic properties and preferential solvation of sulphamethazine in {acetonitrile + water} mixtures using a minimum number of experimental data points. Phys. Chem. Liq. 2020. [Google Scholar] [CrossRef]
  47. Krug, R.R.; Hunter, W.G.; Grieger, R.A. Enthalpy-entropy compensation. 1. Some fundamental statistical problems associated with the analysis of van’t Hoff and arrhenius data. J. Phys. Chem. 1976, 80, 2335–2341. [Google Scholar] [CrossRef]
  48. Krug, R.R.; Hunter, W.G.; Grieger, R.A. Enthalpy-entropy compensation. 2. Separation of the chemical from the statistical effect. J. Phys. Chem. 1976, 80, 2341–2351. [Google Scholar] [CrossRef]
  49. Delgado, D.R.; Jouyban, A.; Martínez, F. Solubility and preferential solvation of meloxicam in methanol+ water mixtures at 298.15 K. J. Mol. Liq. 2014, 197, 368–373. [Google Scholar] [CrossRef]
  50. Blanco-Márquez, J.H.; Ortiz, C.P.; Cerquera, N.E.; Martínez, F.; Jouyban, A.; Delgado, D.R. Thermodynamic analysis of the solubility and preferential solvation of sulfamerazine in (acetonitrile + water) cosolvent mixtures at different temperatures. J. Mol. Liq. 2019, 293, 111507. [Google Scholar] [CrossRef]
  51. Valvani, S.C.; Yalkowsky, S.H.; Amidon, G.L. Solubility of nonelectrolytes in polar solvents. VI. Refinements in molecular surface area computations. J. Phys. Chem. 1976, 80, 829–835. [Google Scholar] [CrossRef]
  52. Machatha, S.G.; Bustamante, P.; Yalkowsky, S.H. Deviation from linearity of drug solubility in ethanol/water mixtures. Int. J. Pharm. 2004, 283, 83–88. [Google Scholar] [CrossRef] [PubMed]
  53. Volkova, T.V.; Levshin, I.B.; Perlovich, G.L. New antifungal compound: Solubility thermodynamics and partitioning processes in biologically relevant solvents. J. Mol. Liq. 2020, 310, 113148. [Google Scholar] [CrossRef]
  54. Perlovich, G.L.; Strakhova, N.N.; Kazachenko, V.P.; Volkova, T.V.; Tkachev, V.V.; Schaper, K.J.; Raevsky, O.A. Sulfonamides as a subject to study molecular interactions in crystals and solutions: Sublimation, solubility, solvation, distribution and crystal structure. Int. J. Pharm. 2008, 349, 300–313. [Google Scholar] [CrossRef]
  55. Bustamante, P.; Escalera, B. Enthalpy and Entropy Contributions to the Solubility of Sulphamethoxypyridazine in Solvent Mixtures Showing Two Solubility Maxima. J. Pharm. Pharmacol. 1995, 47, 550–555. [Google Scholar] [CrossRef]
  56. Bustamante, E.P.; Ochoa, R.; Reillo, A.; Escalera, J.-B. Chameleonic Effect of Sulfanilamide and Sulfamethazine in Solvent Mixtures. Solubility Curves with Two Maxima. Chem. Pharm. Bull. 1994, 42, 1129–1133. [Google Scholar] [CrossRef] [Green Version]
  57. Ben-Naim, A. Theory of preferential solvation of nonelectrolytes. Cell Biophys. 1988, 12, 255–269. [Google Scholar] [CrossRef]
  58. Ben-Naim, A. Theoretical aspects of self-assembly of proteins: A Kirkwood-Buff-theory approach. J. Chem. Phys. 2013, 138, 06B609_1. [Google Scholar] [CrossRef] [PubMed]
  59. Ben-Naim, A.; Navarro, A.M.; Leal, J.M. A Kirkwood-Buff analysis of local properties of solutions. Phys. Chem. Chem. Phys. 2008, 10, 2451–2460. [Google Scholar] [CrossRef] [PubMed]
  60. Marcus, Y. Solvent Mixtures: Properties and Selective Solvation; CRC Press: New York, NY, USA, 2002. [Google Scholar]
  61. Marcus, Y. On the preferential solvation of drugs and PAHs in binary solvent mixtures. J. Mol. Liq. 2008, 140, 61–67. [Google Scholar] [CrossRef]
  62. Delgado, D.R.; Vargas, E.F.; Martínez, F. Preferential solvation of xylitol in ethanol + water co-solvent mixtures according to the IKBI and QLQC methods. Rev. Colomb. Quim. 2013, 42, 125–133. [Google Scholar]
  63. Marcus, Y. Preferential solvation in mixed solvents. 16. Mixtures of N,N-dimethylformamide or propylene carbonate with organic solvents. J. Chem. Thermodyn. 2020, 140, 105903. [Google Scholar] [CrossRef]
  64. Delgado, D.R.; Peña, M.A.; Martínez, F. Preferential solvation of acetaminophen in ethanol + water solvent mixtures according to the inverse Kirkwood-Buff integrals method. Rev. Colomb Cienc. Químico Farm. 2013, 42, 298–314. [Google Scholar]
  65. Marcus, Y. Preferential solvation in mixed solvents. 15. Mixtures of acetonitrile with organic solvents. J. Chem. Thermodyn. 2019, 135, 55–59. [Google Scholar] [CrossRef]
  66. Castro, J.J.S.; Ortiz, C.P.; Rodríguez-Rubiano, J.D.; Rodríguez-Rodríguez, G.A.; Delgado, D.R. Preferential solvation of tricin in {ethanol (1) + water (2)} mixtures at several temperatures. Rev. Colomb. Cienc. Químico Farm. 2018, 47, 135–148. [Google Scholar] [CrossRef] [Green Version]
  67. Marcus, Y. Preferential solvation. Part 3.—Binary solvent mixtures. J. Chem. Soc. Faraday Trans. 1 Phys. Chem. Condens. Phases. 1989, 85, 381–388. [Google Scholar] [CrossRef]
  68. Marcus, Y. The Properties of Solvents; John Wiley & Sons Ltd.: New York, NY, USA, 1999. [Google Scholar]
  69. Jiménez, J.; Manrique, J.; Martínez, F. Effect of temperature on some volumetric properties for ethanol + water mixtures. Rev. Colomb. Cienc. Químico Farm. 2004, 33, 145–155. [Google Scholar]
  70. Aldana, G.A.d.A.; Rubio, D.I.C.; Rodríguez, G.A.R.; Lozano, A.C.; Mehrdad, A.; Delgado, D.R.; Carmona, N.A.P. Solution thermodynamics and preferential solvation of 3-chloro-N-phenyl-phthalimide in acetone + methanol mixtures. Rev. Colomb. Cienc. Químico Farm. 2016, 45, 256. [Google Scholar] [CrossRef] [Green Version]
  71. Taft, R.W.; Kamlet, M.J. The Solvatochromic Comparison Method. 2. The α-Scale of Solvent Hydrogen-Bond Donor (HBD) Acidities. J. Am. Chem. Soc. 1976, 98, 2886–2894. [Google Scholar] [CrossRef]
  72. Noubigh, A. Stearic acid solubility in mixed solvents of (water + ethanol) and (ethanol + ethyl acetate): Experimental data and comparison among different thermodynamic models. J. Mol. Liq. 2019, 296, 112101. [Google Scholar] [CrossRef]
  73. Noubigh, A.; Aydi, A.; Abderrabba, M. Experimental measurement and correlation of solubility data and thermodynamic properties of protocatechuic acid in four organic solvents. J. Chem. Eng. Data 2017, 60, 514–518. [Google Scholar] [CrossRef]
  74. Noubigh, A.; Akremi, A. Solution thermodynamics of trans-Cinnamic acid in (methanol + water) and (ethanol + water) mixtures at different temperatures. J. Mol. Liq. 2019, 274, 752–758. [Google Scholar] [CrossRef]
Figure 1. Molecular structure of amygdalin.
Figure 1. Molecular structure of amygdalin.
Pharmaceuticals 13 00395 g001
Figure 2. Experimental solubility of amygdalin (3) in mole fraction (103x3) as a function of temperature (A); as a function of composition of solvent mixtures (B); and as a function of Hildebrand solubility parameter δ1 + 2 of the [ethanol (1) + water (2)] mixtures (C). For A, ○: EtOH; ◊: x1 = 0.8; ■: x1 = 0.6; ▲: water; ♦: x1 = 0.2; and ●: x1 = 0.4, and for B and C, x: 293.15 K; □: 298.15 K; ■: 303.15; ∆: 308.15; ▲: 310.15 K; ♦: 313.15 K; ◊: 318.15 K; ●: 323.15 K; and ○: 328.15 K.
Figure 2. Experimental solubility of amygdalin (3) in mole fraction (103x3) as a function of temperature (A); as a function of composition of solvent mixtures (B); and as a function of Hildebrand solubility parameter δ1 + 2 of the [ethanol (1) + water (2)] mixtures (C). For A, ○: EtOH; ◊: x1 = 0.8; ■: x1 = 0.6; ▲: water; ♦: x1 = 0.2; and ●: x1 = 0.4, and for B and C, x: 293.15 K; □: 298.15 K; ■: 303.15; ∆: 308.15; ▲: 310.15 K; ♦: 313.15 K; ◊: 318.15 K; ●: 323.15 K; and ○: 328.15 K.
Pharmaceuticals 13 00395 g002
Figure 3. Plot of calculated versus experimental solubility data of amygdalin in {ethanol (1) + water (2)} cosolvent mixtures (▲ = van’t Hoff, □ = Buchowski–Ksiazczak, and ◊ = Jouyban–Acree–van’t Hoff).
Figure 3. Plot of calculated versus experimental solubility data of amygdalin in {ethanol (1) + water (2)} cosolvent mixtures (▲ = van’t Hoff, □ = Buchowski–Ksiazczak, and ◊ = Jouyban–Acree–van’t Hoff).
Pharmaceuticals 13 00395 g003
Figure 4. The van’t Hoff plots for amygdalin in {ethanol (1) + water (2)} cosolvent mixtures (●: x1 = 0.0; ♦: x1 = 0.5; and ▲: x1 = 1.0).
Figure 4. The van’t Hoff plots for amygdalin in {ethanol (1) + water (2)} cosolvent mixtures (●: x1 = 0.0; ♦: x1 = 0.5; and ▲: x1 = 1.0).
Pharmaceuticals 13 00395 g004
Figure 5. Enthalpy–entropy compensation graph of ΔsolnH° vs. ΔsolnG° at Thm = 310.22 K.
Figure 5. Enthalpy–entropy compensation graph of ΔsolnH° vs. ΔsolnG° at Thm = 310.22 K.
Pharmaceuticals 13 00395 g005
Figure 6. Enthalpy–entropy compensation graph of ΔsolnHo vs. TΔsolnSo at Thm = 310.22 K.
Figure 6. Enthalpy–entropy compensation graph of ΔsolnHo vs. TΔsolnSo at Thm = 310.22 K.
Pharmaceuticals 13 00395 g006
Figure 7. Gibbs energy of transfer of amygdalin (3) from pure water (2) to {ethanol (1) + water (2)} mixtures at several temperatures: □: 293.15 K; ●: 298.15 K; ♦: 303.15 K; ■: 308.15 K; and ▲: 313.15 K.
Figure 7. Gibbs energy of transfer of amygdalin (3) from pure water (2) to {ethanol (1) + water (2)} mixtures at several temperatures: □: 293.15 K; ●: 298.15 K; ♦: 303.15 K; ■: 308.15 K; and ▲: 313.15 K.
Pharmaceuticals 13 00395 g007
Figure 8. The δx1,3 values of amygdalin (3) in {ethanol (1) + water (2)} mixtures at mixtures ●: 293.15 K; ○: 298.15 K; ♦: 303.15; ■: 308.15 K; and ▲: 313.15 K.
Figure 8. The δx1,3 values of amygdalin (3) in {ethanol (1) + water (2)} mixtures at mixtures ●: 293.15 K; ○: 298.15 K; ♦: 303.15; ■: 308.15 K; and ▲: 313.15 K.
Pharmaceuticals 13 00395 g008
Table 1. Experimental solubility of amygdalin (3) expressed in molar fraction (103x3 a) in [ethanol (1) + water (2)] mixtures at different temperatures. Experimental pressure p: 0.1 MPa b.
Table 1. Experimental solubility of amygdalin (3) expressed in molar fraction (103x3 a) in [ethanol (1) + water (2)] mixtures at different temperatures. Experimental pressure p: 0.1 MPa b.
x1c,dTemperature/K e
293.15298.15303.15308.15310.15313.15318.15323.15328.15
0.002.543.254.195.496.077.047.919.7311.0
0.102.803.554.616.166.697.838.8610.812.9
0.203.073.995.217.127.428.8410.412.214.6
0.303.344.485.848.088.329.9011.813.616.9
0.403.565.066.608.399.3211.013.315.318.3
0.503.124.064.845.905.997.268.679.5212.1
0.602.202.583.173.944.144.815.556.307.89
0.701.531.882.142.522.833.253.774.125.45
0.801.001.211.361.701.762.022.442.622.93
0.900.710.830.911.121.151.271.351.571.70
1.000.510.560.610.650.690.770.910.941.03
a Average relative uncertainty in mole fraction solubility is u(x3) = 0.025. b Standard uncertainty in pressure u(p) = 0.001 MPa. c x1 is the mole fraction of ethanol (1) in the {ethanol (1) + water (2)} mixtures free of amygdalin (3). d Average relative standard uncertainty in x1 is ur(x1) = 0.01. e T is the absolute temperature. Standard uncertainty in temperature is u(T) = 0.05 K.
Table 2. Estimation of the solubility parameter of amygdalin by Fedor’s method [34].
Table 2. Estimation of the solubility parameter of amygdalin by Fedor’s method [34].
Group or AtomQuantity∆V (cm3 mol−1)∆U (kJ mol−1)
–CH2216.14.94
–CH<1113.54.31
–OH71029.8
–O–43.83.35
–C≡N12425.5
Phenyl171.431.9
Ring closure1161.05
Total377.3337.74
δ3 = (337,740/377.3)1/2 = 29.9 MPa1/2
Table 3. Thermodynamic functions of dissolution processes of amygdalin in {ethanol (1) + water (2)} cosolvent mixtures at Thm = 310.22 K.
Table 3. Thermodynamic functions of dissolution processes of amygdalin in {ethanol (1) + water (2)} cosolvent mixtures at Thm = 310.22 K.
x1aΔsolnGo/
kJ mol−1
ΔsolnHo/
kJ mol−1
ΔsolnSo/
J mol−1 K−1
solnSo/
kJ mol−1
ζH bζTS b
0.0013.3134.1067.0320.790.6210.379
0.1013.0235.3471.9322.310.6130.387
0.2012.7135.8674.6223.150.6080.392
0.3012.4136.7778.5224.360.6010.399
0.4012.1537.0480.2124.880.5980.402
0.5013.0729.9254.3116.850.6400.360
0.6014.1329.1048.2614.970.6600.340
0.7015.1228.1441.9513.010.6840.316
0.8016.3225.3629.149.040.7370.263
0.9017.4820.268.962.780.8790.121
1.0018.6617.03−5.25−1.630.9130.087
ax1 is the mole fraction of ethanol (1) in the {ethanol (1) + water (2)} mixtures free of amygdalin (3). Standard uncertainty in T is u(T) = 0.10 K. Average relative standard uncertainties in apparent thermodynamic quantities of real dissolution processes are ur(∆solnG°) = 0.02, ur(∆solnH°) = 0.02, ur(∆solnS°) = 0.03, and ur(TsolnS°) = 0.03. b ζH and ζTS are the relative contributions by enthalpy and entropy toward apparent Gibbs energy of dissolution.
Table 4. Coefficients of the Equation (22) to Gibbs energy of transfer of amygdalin (3) at several temperatures.
Table 4. Coefficients of the Equation (22) to Gibbs energy of transfer of amygdalin (3) at several temperatures.
Coefficient293.15 K298.15 K303.15 K308.15 K313.15 K
a−0.00220.03560.04460.08790.0706
b−0.3574−1.27821.8586−5.1881−3.8227
c−20.48−19.625−18.477−1.9751−8.7567
d53.77555.87457.34932.2643.505
e−29.053−30.73532.277−19.838−25.332
R20.9980.9940.9950.9930.994
Table 5. The δx1,3 values of amygdalin in {ethanol (1) + water (2)} mixtures at some temperatures.
Table 5. The δx1,3 values of amygdalin in {ethanol (1) + water (2)} mixtures at some temperatures.
x1 aδx1,3
293.15298.15303.15308.15313.15
0.0000.0000.0000.0000.0000.000
0.050−0.001−0.001−0.001−0.002−0.001
0.100−0.001−0.002−0.002−0.002−0.002
0.150−0.001−0.002−0.002−0.002−0.002
0.200−0.001−0.001−0.001−0.001−0.001
0.2500.0000.0000.0000.0000.000
0.3000.0010.0010.0000.0000.000
0.3500.0000.000−0.001−0.002−0.002
0.400−0.002−0.003−0.004−0.005−0.005
0.450−0.007−0.008−0.009−0.010−0.010
0.500−0.014−0.015−0.017−0.017−0.017
0.550−0.023−0.024−0.026−0.026−0.026
0.600−0.033−0.035−0.037−0.036−0.036
0.650−0.043−0.046−0.048−0.046−0.047
0.700−0.051−0.054−0.056−0.054−0.056
0.750−0.052−0.055−0.058−0.057−0.059
0.800−0.044−0.047−0.050−0.051−0.054
0.850−0.030−0.033−0.035−0.037−0.039
0.900−0.016−0.017−0.018−0.021−0.022
0.950−0.005−0.005−0.006−0.008−0.008
1.0000.0000.0000.0000.0000.000
ax1 is the mole fraction of ethanol (1) in the {ethanol (1) + water (2)} mixtures free of amygdalin (3).
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Aydi, A.; Ayadi, C.; Ghachem, K.; Al-Khazaal, A.Z.; Delgado, D.R.; Alnaief, M.; Kolsi, L. Solubility, Solution Thermodynamics, and Preferential Solvation of Amygdalin in Ethanol + Water Solvent Mixtures. Pharmaceuticals 2020, 13, 395. https://doi.org/10.3390/ph13110395

AMA Style

Aydi A, Ayadi C, Ghachem K, Al-Khazaal AZ, Delgado DR, Alnaief M, Kolsi L. Solubility, Solution Thermodynamics, and Preferential Solvation of Amygdalin in Ethanol + Water Solvent Mixtures. Pharmaceuticals. 2020; 13(11):395. https://doi.org/10.3390/ph13110395

Chicago/Turabian Style

Aydi, Abdelkarim, Cherifa Ayadi, Kaouther Ghachem, Abdulaal Z. Al-Khazaal, Daniel R. Delgado, Mohammad Alnaief, and Lioua Kolsi. 2020. "Solubility, Solution Thermodynamics, and Preferential Solvation of Amygdalin in Ethanol + Water Solvent Mixtures" Pharmaceuticals 13, no. 11: 395. https://doi.org/10.3390/ph13110395

APA Style

Aydi, A., Ayadi, C., Ghachem, K., Al-Khazaal, A. Z., Delgado, D. R., Alnaief, M., & Kolsi, L. (2020). Solubility, Solution Thermodynamics, and Preferential Solvation of Amygdalin in Ethanol + Water Solvent Mixtures. Pharmaceuticals, 13(11), 395. https://doi.org/10.3390/ph13110395

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop